Microencapsulation of a cyclodextrin complex of the UV filter, butyl methoxydibenzoylmethane: In vivo skin penetration studies

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 2, 2011, Pages 345-350

  Scalia, Santo ^a   Coppi, Gilberto ^b   Iannuccelli, Valentina ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Butyl methoxydibenzoylmethane; Cyclodextrins; In vivo percutaneous penetration; Lipid microparticles; Sunscreens; Tape stripping

Indexed keywords

AVOBENZONE; CYCLODEXTRIN; PHOSPHATIDYLCHOLINE; SUNSCREEN; TRISTEARIN;

ARTICLE; CREAM; DRUG FORMULATION; DRUG PENETRATION; DRUG STRUCTURE; EMULSION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MICROENCAPSULATION; NORMAL HUMAN; PRIORITY JOURNAL; SKIN PENETRATION; STRATUM CORNEUM; ULTRAVIOLET RADIATION;

ADULT; ALKANES; BETA-CYCLODEXTRINS; CHALCONES; CYCLODEXTRINS; DRUG COMPOUNDING; EMULSIONS; FILTRATION; HUMANS; HYDROGENATION; LIPIDS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MIDDLE AGED; MOLECULAR STRUCTURE; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; SKIN; SKIN ABSORPTION; SUNSCREENING AGENTS; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES; ULTRAVIOLET RAYS;

EID: 78650182190     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.09.018     Document Type: Article

References (32)

1. European Union: Commission Recommendation 2006/647/EC on the efficacy of sunscreen products and the claims made relating thereto. Official J. Eur. Union L 2006, 265:39-43.
2. Lautenschlager S., Wulf H.C., Pittelkow M.R. Photoprotection. Lancet 2007, 370:528-537.
3. Nohynek G.J., Schaefer H. Benefit and risk of organic ultraviolet filters. Regul. Toxicol. Pharmacol. 2001, 332:285-299.
4. Herzog B., Hueglin D., Osterwalder U. New sunscreen actives. Sunscreens 2005, Taylor Francis Group, Boca Raton, FL, pp. 293, 296, 317. third ed. N. Shaath (Ed.).
5. Chatelain E., Gabard B., Surber C. Skin penetration and sun protection factor of five UV filters: effect of the vehicle. Skin Pharmacol. Appl. Skin Physiol. 2003, 16:28-35.
6. Hagedorn-Leweke U., Lippold B.C. Absorption of sunscreens and other compounds through human skin in vivo: derivation of a method to predict maximum fluxes. Pharm. Res. 1995, 12:1354-1360.
7. Simeoni S., Scalia S., Benson H.A.E. Influence of cyclodextrins on in vitro human skin absorption of the sunscreen, butyl-methoxydibenzoylmethane. Int. J. Pharm. 2004, 280:163-171.
8. Yener G., Incegül T., Yener N. Importance of using solid lipid microspheres as carriers for UV filters on the example of octyl methoxy cinnamate. Int. J. Pharm. 2003, 258:203-207.
9. Klein K., Palefsky I. Formulating sunscreen products. Sunscreens 2005, Taylor Francis Group, Boca Raton, FL, pp. 356, 370. third ed. N. Shaath (Ed.).
10. Steinberg D.C. Regulations of sunscreens worldwide. Sunscreens 2005, 180-183. Taylor Francis Group, Boca Raton, FL. third ed. N. Shaath (Ed.).
11. Hayden C.G.J., Cross S.E., Anderson C., Saunders N.A., Roberts M.S. Sunscreen penetration of human skin and related keratinocyte toxicity after topical application. Skin Pharmacol. Physiol. 2005, 18:170-174.
12. Iannuccelli V., Coppi G., Sergi S., Mezzena M., Scalia S. In vivo and in vitro skin penetration of butyl methoxydibenzoylmethane from lipospheres. Skin Pharmacol. Physiol. 2008, 21:30-38.
13. Scalia S., Villani S., Scatturin A., Vandelli M.A., Forni F. Complexation of the sunscreen agent, butyl-methoxydibenzoylmethane, with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 1998, 175:205-213.
14. Scalia S., Simeoni S., Barbieri A., Sostero S. Influence of hydroxypropyl-β-cyclodextrin on photo-induced free radical production by the sunscreen agent, butyl-methoxydibenzoylmethane. J. Pharm. Pharmacol. 2002, 54:1553-1558.
15. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 1996, 85:1017-1025.
16. Rajewski R.A., Stella V.J. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 1996, 85:1142-1169.
17. Scalia S., Tursilli R., Sala N., Iannucceli V. Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 2006, 320:79-85.
18. Jaspart S., Piel G., Delattre L., Evrard B. Solid lipid microparticles: formulation, preparation, characterization, drug release and applications. Expert Opin. Drug Deliv. 2005, 2:75-87.
19. Scalia S., Tursilli R., Iannuccelli V. Complexation of the sunscreen agent, 4-methylbenzylidene camphor with cyclodextrin: effect on photostability and human stratum corneum penetration. J. Pharm. Biomed. Anal. 2007, 44:29-34.
20. COLIPA - The European Cosmetic, Toiletry and Perfumery Association Cosmetic ingredients. Guidelines for percutaneous absorption/penetration August 1997.
21. Shah V.P., Flynn G.L., Yacobi A., Maibach H.I., Bon C., Fleischer N.M., Franz T.J., Kaplan S.A., Kawamoto J., Lesko L.J., Marty J.P., Pershing L.K., Schaefer H., Sequeira J.A., Shrivastava S.P., Wilkin J., Williams R.L. AAPS/FDA workshop report: bioequivalence of topical dermatological dosage forms - methods of evaluation of bioequivalence. Pharm. Res. 1998, 15:167-171.
22. Schaefer H., Watts F., Brod J., Illel B. Follicular penetration. Prediction of Percutaneous Penetration. Methods, Measurements, Modeling 1990, 163-173. IBC Technical Services, London. R.C. Scott, R.H. Guy, J. Hadgraft (Eds.).
23. European Commission, Scientific Committee on Consumer Products, SCCP/0970/06, Basic Criteria for the In Vitro Assessment of Dermal Absorption of Cosmetic Ingredients. (updated March 2006).
24. Gabbanini S., Lucchi E., Carli M., Berlini E., Minghetti A., Valgimigli L. In vitro evaluation of the permeation through reconstructed human epidermis of essentials oils from cosmetic formulations. J. Pharm. Biomed. Anal. 2009, 50:370-376.
25. Organisation for Economic Cooperation and Development, Guidelines for Testing of Chemicals, Guideline 428, Skin Absorption - In Vitro Method 2004, OECD, Paris.
26. Fernandez C., Nielloud F., Fortuné R., Vian L., Marti-Mestres G. Benzophenone-3: rapid prediction and evaluation using non-invasive methods of in vivo human penetration. J. Pharm. Biomed. Anal. 2002, 28:57-63.
27. Weigmann H.J., Lademann J., Schanze S., Lindemann U., von Pelchrzim R., Schaefer H., Sterry W., Shah V. Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability. Skin Pharmacol. Appl. Skin Physiol. 2001, 14:98-102.
28. Loftsson T., Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharm. 2001, 225:15-30.
29. Yang J., Wiley C.J., Godwin D.A., Felton L.A. Influence of hydroxypropyl-β-cyclodextrin on transdermal penetration and photostability of avobenzone. Eur. J. Pharm. Biopharm. 2008, 69:605-612.
30. Matsuda H., Arima H. Cyclodextrins in transdermal and rectal delivery. Adv. Drug Deliv. Rev. 1999, 36:81-99.
31. Toll R., Jacobi U., Ritcher H., Lademann J., Schaefer H., Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J. Invest. Dermatol. 2004, 123:168-176.
32. Nasr M., Mansour S., Mortada N.D., El Shamy A.A. Lipospheres as carrier for topical delivery of acetoclofenac: preparation, characterization and in vivo evaluation. AAPS Pharm. Sci. Tech. 2008, 9:154-161.